US Edition
New drug lowers blood sugar and increases fat burning without negatively affecting appetite or muscle mass
Summary by bariatricnews.net
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
All
Left
Center
Right
SANA acts directly in the cells of the adipative tissue and does not act in the central nervous system or in the digestive system. Phase 2 of the study should begin this year.
·Brazil
Read Full Article
New drug lowers blood sugar and increases fat burning without negatively affecting appetite or muscle mass
A new potential drug lowers blood sugar and increases fat burning without negatively affecting appetite or muscle mass, according to a new study by researchers from Karolinska Institutet and Stockholm University.The new drug, which is taken in tablet form, has a completely different mechanism of action than the well-known GLP-1-based drugs, administered via injections. GLP-1 drugs affect hunger via signals between the gut and the brain, but ofte…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
